Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute myeloid leukemia.

× No keyword cloud information.

375 in total

1. A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.

Authors: Y Boumber; H Kantarjian; J Jorgensen; S Wen; S Faderl; R Castoro; J Autry; G Garcia-Manero; G Borthakur; E Jabbour; Z Estrov; J Cortes; J-P Issa; F Ravandi
Journal: Leukemia Date: 2012-06-05 Impact factor: 11.528

2. Initial presentation of childhood leukaemia with facial palsy: three case reports.

Authors: Mehran Karimi; Nader Cohan; Soheila Zareifar; Sorror Inaloo; Sina Kalikias; Sam Moslemi
Journal: BMJ Case Rep Date: 2009-12-09

Review 3. A potential role of ruxolitinib in leukemia.

Authors: Kiran Naqvi; Srdan Verstovsek; Hagop Kantarjian; Farhad Ravandi
Journal: Expert Opin Investig Drugs Date: 2011-06-03 Impact factor: 6.206

4. Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.

Authors: Roland B Walter; Frederick R Appelbaum; Martin S Tallman; Noel S Weiss; Richard A Larson; Elihu H Estey
Journal: Blood Date: 2010-06-10 Impact factor: 22.113

5. Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapy.

Authors: Steven M Kornblau; Mark D Minden; David B Rosen; Santosh Putta; Aileen Cohen; Todd Covey; David C Spellmeyer; Wendy J Fantl; Urte Gayko; Alessandra Cesano
Journal: Clin Cancer Res Date: 2010-06-04 Impact factor: 12.531

6. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.

Authors: Zejuan Li; Tobias Herold; Chunjiang He; Peter J M Valk; Ping Chen; Vindi Jurinovic; Ulrich Mansmann; Michael D Radmacher; Kati S Maharry; Miao Sun; Xinan Yang; Hao Huang; Xi Jiang; Maria-Cristina Sauerland; Thomas Büchner; Wolfgang Hiddemann; Abdel Elkahloun; Mary Beth Neilly; Yanming Zhang; Richard A Larson; Michelle M Le Beau; Michael A Caligiuri; Konstanze Döhner; Lars Bullinger; Paul P Liu; Ruud Delwel; Guido Marcucci; Bob Lowenberg; Clara D Bloomfield; Janet D Rowley; Stefan K Bohlander; Jianjun Chen
Journal: J Clin Oncol Date: 2013-02-04 Impact factor: 44.544

7. A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.

Authors: Daniel J Deangelo; Donna Neuberg; Philip C Amrein; Jacob Berchuck; Martha Wadleigh; L Andres Sirulnik; Ilene Galinsky; Todd Golub; Kimberly Stegmaier; Richard M Stone
Journal: Leuk Res Date: 2013-11-05 Impact factor: 3.156

8. Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells.

Authors: Polina Zjablovskaja; Petr Danek; Miroslava Kardosova; Meritxell Alberich-Jorda
Journal: J Vis Exp Date: 2018-02-21 Impact factor: 1.355

9. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.

Authors: M Ryan Corces-Zimmerman; Wan-Jen Hong; Irving L Weissman; Bruno C Medeiros; Ravindra Majeti
Journal: Proc Natl Acad Sci U S A Date: 2014-02-03 Impact factor: 11.205

10. Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia.

Authors: Alison R Walker; Rebecca Klisovic; Jeffrey S Johnston; Yao Jiang; Susan Geyer; Cheryl Kefauver; Philip Binkley; John C Byrd; Michael R Grever; Ramiro Garzon; Mitch A Phelps; Guido Marcucci; Kristie A Blum; William Blum
Journal: Leuk Lymphoma Date: 2013-01-24